Breaking News Instant updates and real-time market news.

IPGP

IPG Photonics

$131.30

-3.46 (-2.57%)

08:09
10/30/18
10/30
08:09
10/30/18
08:09

IPG Photonics lowers FY18 revenue growth view to 1%-4% from 7%-9%

  • 30

    Oct

IPGP IPG Photonics
$131.30

-3.46 (-2.57%)

10/08/18
10/08/18
DOWNGRADE

Neutral
Northcoast downgrades IPG Photonics, peers to Neutral as outlook lacks clarity
As previously reported, Northcoast analyst Tom Hayes downgraded IPG Photonics (IPGP), Coherent (COHR), and nLIGHT (LASR) to Neutral from Buy as he sees considerable headwinds remaining in place, which will likely constrain unit volume growth over the next few quarters and into 2019. While the analyst continues to expect that industrial lasers, especially fiber lasers, will become an important tool in global manufacturing, the near-term challenges and lack of visibility are moving him to the sidelines as he expects the headwinds to extend into FY19 as trade and tariff issues weigh on demand. Hayes also notes that China is a significant market for laser demand, but its outsized component of total revenue adds some risk to operations. Based on the most recently published reports, trailing 12-month revenue in China represented 43% of IPG revenue, 9% of Coherent revenue, and 39% of nLIGHT's revenue, he adds.
10/09/18
10/09/18
DOWNGRADE

Neutral
Coherent downgraded to Neutral on OLED timing, industrial malaise at Longbow
As previously reported, Longbow analyst Joe Wittine downgraded Coherent (COHR) Neutral from Buy based upon a potentially elongating OLED investment cycle. Wittine views Apple's (AAPL) iPhone XR/LCD dynamic as partially responsible for this extension. Should advanced LCD devices prove to have a longer shelf life, the investment cycle will face extensions, he contends. The analyst also cited the weakening seen in his Q3 industrial laser survey confirmed by IPG Photonics' (IPGP) Q3 preannouncement last week.
10/19/18
BOFA
10/19/18
INITIATION
Target $147
BOFA
Neutral
IPG Photonics reinstated with a Neutral at BofA/Merrill
BofA/Merrill reinstated IPG Photonics with a Neutral and $147 price target citing rising US-China trade tensions and uncertain auto outlook.
10/24/18
NRCS
10/24/18
NO CHANGE
NRCS
Neutral
Northcoast finds modest rebound in Industrial Laser sentiment in September
Northcoast analyst Tom Hayes reported that his September survey of the Industrial Laser industry showed a modest rebound in sentiment following a weak outlook in August. He has seen more mixed market commentary from China as well as Coherent (COHR) indicating that its previous revenue and margin guidance would fall short of expectations following his downgrades of the laser names he covers, noted Hayes. He maintains Neutral ratings on Coherent, IPG Photonics (IPGP) and nLight (LASR).

TODAY'S FREE FLY STORIES

VKTX

Viking Therapeutics

$8.62

-0.15 (-1.71%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Initiation
Viking Therapeutics initiated  »

Viking Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$41.52

-0.7 (-1.66%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Periodicals
U.S China trade negotators seek resolution of Micron-Fujian Jinhua spat, FT says »

U.S. and Chinese trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

XOM

Exxon Mobil

$77.84

-0.7 (-0.89%)

, MSFT

Microsoft

$109.47

2.27 (2.12%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Hot Stocks
Exxon Mobil partners with Microsoft to increase Permian profitability »

ExxonMobil (XOM) said a…

XOM

Exxon Mobil

$77.84

-0.7 (-0.89%)

MSFT

Microsoft

$109.47

2.27 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 01

    Mar

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

EQ

Equillium

$5.76

-0.56 (-8.86%)

09:05
02/22/19
02/22
09:05
02/22/19
09:05
Initiation
Equillium initiated  »

Equillium initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$18.13

-0.99 (-5.18%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Hot Stocks
Yext doubles workforce in France, names Selwa Hussain as EMEA CFO »

Yext announced the growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

ORTX

Orchard Therapeutics

$16.00

(0.00%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Hot Stocks
Orchard Therapeutics presents follow-up data from OTL-101 trial »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRVB

Provention Bio

$2.42

0.09 (3.86%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Initiation
Provention Bio initiated  »

Provention Bio initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNKD

MannKind

$1.45

-0.025 (-1.70%)

09:04
02/22/19
02/22
09:04
02/22/19
09:04
Initiation
MannKind initiated  »

MannKind initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

DERM

Dermira

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Dermira initiated  »

Dermira initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MDGL

Madrigal Pharmaceuticals

$125.62

2.5 (2.03%)

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 19

    Mar

ICPT

Intercept

$91.83

-7.17 (-7.24%)

09:03
02/22/19
02/22
09:03
02/22/19
09:03
Initiation
Intercept initiated  »

Intercept initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

NTRA

Natera

$16.00

-0.17 (-1.05%)

09:02
02/22/19
02/22
09:02
02/22/19
09:02
Hot Stocks
Natera's dd-cfDNA test shows 'superior performance' in study »

Natera announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$1.28

0.08 (6.67%)

09:02
02/22/19
02/22
09:02
02/22/19
09:02
Syndicate
Trillium Therapeutics 18.75M share Spot Secondary priced at 80c »

Cowen acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ROKU

Roku

$51.47

-2.16 (-4.03%)

09:01
02/22/19
02/22
09:01
02/22/19
09:01
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$38.37

-0.76 (-1.94%)

, TSLA

Tesla

$291.18

-11.33 (-3.75%)

09:01
02/22/19
02/22
09:01
02/22/19
09:01
Periodicals
AutoNation CEO says Elon Musk acts in 'almost unethical way', CNBC reports »

AutoNation (AN) outgoing…

AN

AutoNation

$38.37

-0.76 (-1.94%)

TSLA

Tesla

$291.18

-11.33 (-3.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 27

    Feb

  • 18

    Mar

  • 19

    Mar

GLPG

Galapagos NV

$97.83

-3.2 (-3.17%)

09:00
02/22/19
02/22
09:00
02/22/19
09:00
Initiation
Galapagos NV initiated  »

Galapagos NV initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Apr

KL

Kirkland Lake Gold

$36.03

2.6 (7.78%)

08:59
02/22/19
02/22
08:59
02/22/19
08:59
Downgrade
Kirkland Lake Gold rating change  »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CBAY

CymaBay

08:59
02/22/19
02/22
08:59
02/22/19
08:59
Initiation
CymaBay initiated  »

CymaBay initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIN

Albany International

$76.37

-0.285 (-0.37%)

08:58
02/22/19
02/22
08:58
02/22/19
08:58
Initiation
Albany International initiated  »

Albany International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

ATRS

Antares Pharma

$3.21

0.01 (0.31%)

08:58
02/22/19
02/22
08:58
02/22/19
08:58
Recommendations
Antares Pharma analyst commentary  »

Antares Pharma upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

Aveo Pharmaceuticals

$0.62

-0.0047 (-0.75%)

, BMY

Bristol-Myers

$50.15

-1.14 (-2.22%)

08:57
02/22/19
02/22
08:57
02/22/19
08:57
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

AVEO

Aveo Pharmaceuticals

$0.62

-0.0047 (-0.75%)

BMY

Bristol-Myers

$50.15

-1.14 (-2.22%)

EXEL

Exelixis

$21.22

(0.00%)

IMMU

Immunomedics

$14.33

-0.03 (-0.21%)

JNJ

Johnson & Johnson

$135.40

-0.91 (-0.67%)

MRK

Merck

$79.82

0.38 (0.48%)

NKTR

Nektar

$40.26

-2.76 (-6.42%)

PFE

Pfizer

$42.14

-0.07 (-0.17%)

SGEN

Seattle Genetics

$69.25

-0.53 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 06

    Mar

  • 11

    Apr

  • 18

    May

  • 20

    May

  • 17

    Jun

TRIL

Trillium Therapeutics

$1.28

0.08 (6.67%)

08:55
02/22/19
02/22
08:55
02/22/19
08:55
Hot Stocks
Breaking Hot Stocks news story on Trillium Therapeutics »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GE

General Electric

$10.03

-0.07 (-0.69%)

, LLY

Eli Lilly

$122.72

0.05 (0.04%)

08:55
02/22/19
02/22
08:55
02/22/19
08:55
Options
Notable open interest changes for February 22nd »

Thursday's total…

GE

General Electric

$10.03

-0.07 (-0.69%)

LLY

Eli Lilly

$122.72

0.05 (0.04%)

TSLA

Tesla

$291.18

-11.33 (-3.75%)

ELAN

Elanco

$29.07

-0.29 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

  • 18

    Mar

  • 19

    Mar

  • 18

    May

PLAN

Anaplan

08:54
02/22/19
02/22
08:54
02/22/19
08:54
Recommendations
Anaplan analyst commentary  »

Anaplan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

ZG

Zillow

$35.07

0.22 (0.63%)

, Z

Zillow

$35.03

0.22 (0.63%)

08:54
02/22/19
02/22
08:54
02/22/19
08:54
Recommendations
Zillow, Zillow analyst commentary  »

Zillow core business…

ZG

Zillow

$35.07

0.22 (0.63%)

Z

Zillow

$35.03

0.22 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 25

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.